Last reviewed · How we verify

Sevoflurane - Neostigmine 50

Pontificia Universidade Catolica de Sao Paulo · FDA-approved active Small molecule ✓ Verified May 2026 Quality 2/100

Sevoflurane - Neostigmine 50 is a Small molecule drug developed by Pontificia Universidade Catolica de Sao Paulo. It is currently FDA-approved. Also known as: Inhalational anesthesia.

Sevoflurane and Neostigmine 50 are interventions studied in clinical trials for conditions such as neuromuscular blockade and anesthesia. Neostigmine is a small molecule with the synonyms MIOSTIN, NEOSTIGMINE, and others, used in combination with Sevoflurane for these conditions.

At a glance

Generic nameSevoflurane - Neostigmine 50
Also known asInhalational anesthesia
SponsorPontificia Universidade Catolica de Sao Paulo
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Sevoflurane - Neostigmine 50

What is Sevoflurane - Neostigmine 50?

Sevoflurane - Neostigmine 50 is a Small molecule drug developed by Pontificia Universidade Catolica de Sao Paulo.

Who makes Sevoflurane - Neostigmine 50?

Sevoflurane - Neostigmine 50 is developed and marketed by Pontificia Universidade Catolica de Sao Paulo (see full Pontificia Universidade Catolica de Sao Paulo pipeline at /company/pontificia-universidade-catolica-de-sao-paulo).

Is Sevoflurane - Neostigmine 50 also known as anything else?

Sevoflurane - Neostigmine 50 is also known as Inhalational anesthesia.

What development phase is Sevoflurane - Neostigmine 50 in?

Sevoflurane - Neostigmine 50 is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing